Clinical Trial Update: Study of SDMB (2,2 Dimethylbutyrate, Sodium Salt) in Beta Thalassemia Intermedia in Thailand [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial evaluated SDMB (2,2-dimethylbutyrate, sodium salt) for beta-thalassemia intermedia in Thailand and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Beta-thalassemia Intermedia

Drugs mentioned

• SDMB (2,2-dimethylbutyrate, sodium salt) (2,2-dimethylbutyrate sodium salt)

Snippet

Sponsor: Boston University | Conditions: Beta Thalassemia Intermedia | Phase 2 | Status: COMPLETED